Cataract Cases
ZEISS is renowned for its optical expertise in cataract treatment, offering cutting-edge solutions that enhance surgical precision and patient outcomes. With advanced technologies, surgeons benefit from integrated systems that streamline pre-operative planning, support surgical excellence, and provide post-operative analysis. ZEISS commitment to innovation is manifest in its dedication to staying one step ahead in optics. Maximizing patient satisfaction by combining leading technologies ensures a wide variety of high-quality solutions, devices, and consumables that cater to diverse patient needs. Get expert insights and experience the future of cataract surgery, where efficiency meets innovation.
The ZEISS IOL Power Calculation Service. Providing guidance in complex cases
January 15th 2025Advances in biometric technology and IOL calculation formulas have enabled refractive accuracy of cataract and clear lens exchange (CLE) surgery, but IOL power selection remains challenging in some cases. I have found that the ZEISS IOL Power Calculation Service (IPCS) is a valuable asset to help me in these uncertain situations.
My first experiences with AT ELANA 841P and ARTEVO 850
November 5th 2024This article by Liem Trinh, MD highlights his experiences with the AT ELANA® 841P hydrophobic trifocal IOL and the ARTEVO® 750 and ARTEVO® 850 microscopes from ZEISS. Dr. Trinh discusses the benefits of the trifocal design of the AT ELANA 841P IOL and its ability to provide spectacle independence at all distances after cataract surgery. He also shares his positive experiences with the ARTEVO 850 microscope, which offers improved surgical visualization with RGB LED illumination and 3D viewing on a high dynamic range monitor. Additionally, Dr. Trinh discusses the potential benefits of integrated intraoperative optical coherence tomography (OCT) and the redesigned CALLISTO eye user interface.
Onboarding a new trifocal hydrophobic C-loop IOL My early experiences with AT ELANA® 841P from ZEISS
March 22nd 2024Diabetic Retinopathy ranked as the fifth most common cause of blindness among adults aged 50 and older in 2020 according to data from the Global Burden of Disease study. Aude Couturier, MD shares her experience of using advanced imaging technologies to optimize diagnosis and surgical management of her DR patients in our latest Case of the Month.
